Description
RADIOPHARMACEUTICALS- DE-OBLIGATION MOD FOR CONTRACT CLOSE-OUT
Base award description: RADIOPHARMACEUTICALS
Modification chain · 11 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-11-01+$215,032= $215,032
- Mod P000012013-10-01+$221,490= $436,522
- Mod P000022013-10-18+$14,361= $450,883
- Mod P000032014-02-06+$302= $451,184
- Mod P000042014-08-20-$44,769= $406,415
- Mod P000052014-10-01+$238,762= $645,177
- Mod P000062015-02-10-$5,123= $640,054
- Mod P000072015-10-01+$234,971= $875,025
- Mod P000082016-05-02-$17,528= $857,497
- Mod P000092019-07-01-$302= $857,196
- Mod P000102020-06-08-$11,289= $845,906
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-11-01 | +$215,032 | $215,032 | RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2013-10-01 | +$221,490 | $436,522 | RADIOPHARMACEUTICALS |
| Mod P00002· EXERCISE AN OPTION | 2013-10-18 | +$14,361 | $450,883 | RADIOPHARMACEUTICALS |
| Mod P00003· FUNDING ONLY ACTION | 2014-02-06 | +$302 | $451,184 | RADIOPHARMACEUTICALS |
| Mod P00004· FUNDING ONLY ACTION | 2014-08-20 | −$44,769 | $406,415 | RADIOPHARMACEUTICALS |
| Mod P00005· EXERCISE AN OPTION | 2014-10-01 | +$238,762 | $645,177 | RADIOPHARMACEUTICALS |
| Mod P00006· FUNDING ONLY ACTION | 2015-02-10 | −$5,123 | $640,054 | RADIOPHARMACEUTICALS |
| Mod P00007· EXERCISE AN OPTION | 2015-10-01 | +$234,971 | $875,025 | RADIOPHARMACEUTICALS |
| Mod P00008· FUNDING ONLY ACTION | 2016-05-02 | −$17,528 | $857,497 | RADIOPHARMACEUTICALS- DE-OBLIGATION MOD FOR CONTRACT CLOSE-OUT |
| Mod P00009· FUNDING ONLY ACTION | 2019-07-01 | −$302 | $857,196 | RADIOPHARMACEUTICALS- DE-OBLIGATION MOD FOR CONTRACT CLOSE-OUT |
| Mod P00010· FUNDING ONLY ACTION | 2020-06-08 | −$11,289 | $845,906 | RADIOPHARMACEUTICALS- DE-OBLIGATION MOD FOR CONTRACT CLOSE-OUT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI NRMNYAAVZ767)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25522N0051 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $7,678 | FY2022 |
| 36C25521N0048 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $145,047 | FY2021 |
| 36C24120N0016 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $368,096 | FY2020 |
| 36C25519N0519 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6505 · DRUGS AND BIOLOGICALS | $134,688 | FY2019 |
| 36C24419P0012 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $30,306 | FY2019 |
| 36C24819N0033 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $125,065 | FY2019 |
Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126P1178 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
| 36C26126P1102 | ENVIGO RMS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $74,586 | FY2026 |
| 36C26126P0961 | 10X GENOMICS, INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $34,600 | FY2026 |
| 36C26126P0997 | SIERRA RADIOPHARMACY LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $247,204 | FY2026 |
| 36C26126P1008 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26113C0018_3600_-NONE-_-NONE- · retrieved 2026-09-26.